Wall Street has been focused on Novo Nordisk, Eli Lilly and other large drugmakers hoping to join the weight loss drug market, such as Pfizer, Roche and Amgen.
from Business News https://ift.tt/PNMcB9l
from Business News https://ift.tt/PNMcB9l